NeoGenomics (NEO) Form 3 NEOGENOMICS / Denise E Pedulla ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Pedulla Denise E

(Last) (First) (Middle)

12701 COMMONWEALTH DRIVE

SUITE 9

(Street)

FORT MYERS FL 33913

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/19/2020

3. Issuer Name and Ticker or Trading Symbol
NEOGENOMICS INC [ NEO ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
General Counsel

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	41,076	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock	12/08/2016(1)	12/08/2020	Common Stock	15,000	7.85	D
Common Stock	04/28/2018(2)	04/28/2022	Common Stock	25,000	7.52	D
Common Stock	02/26/2019(3)	02/26/2023	Common Stock	48,334	8.03	D
Common Stock	03/01/2020(4)	03/01/2024	Common Stock	17,496	19.6	D

Explanation of Responses:

1. On December 8, 2015, Ms. Pedulla was granted an option to purchase 60,000 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first four anniversary dates of the grant date.

2. On April 28, 2017, Ms. Pedulla was granted an option to purchase 75,000 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.

3. On January 26, 2018, Ms. Pedulla was granted an option to purchase 72,500 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first three anniversary dates of the grant date.

4. On March 1, 2019, Ms. Pedulla was granted an option to purchase 17,496 shares of NeoGenomics, Inc. common stock. The options vest ratably over the first four anniversary dates of the grant date.

Remarks:

	/s/ Denise E Pedulla	02/28/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.